Markets
← Back to Stocks
A
AGILENT TECHNOLOGIES INC
Health Care · Life Sciences Tools & Services
$111.72
+0.29%
Vol: 0.1M
Araverus Market Read
Thursday, March 19, 2026
Agilent Q1 EPS miss drives stock decline, analysts see 31% upside potential
Agilent Technologies Q1 fiscal 2026 EPS $1.36 fell just below anticipated $1.37 with revenue $1.8 billion under forecasted $1.81 billion. Stock declined 10% over past month and 28.3% from 52-week high at $111.99 pre-market. Analysts see potential 31% upside based on intrinsic valuations despite recent weakness.
Price 50d 200d
Previous Market Reads
2 of 2 days↓
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LLYELI | $916.83 | -0.13% | -11.4% | 21.8x | 0.43 | $821.2B |
| JNJJOHNSON | $237.56 | +0.16% | -1.8% | 18.9x | 0.33 | $572.6B |
| ABBVABBVIE | $206.31 | -0.97% | -11.4% | 12.8x | 0.33 | $364.6B |
| MRKMERCK | $114.17 | -0.29% | -5.4% | 11.7x | 0.26 | $282.3B |
| UNHUNITEDHEALTH | $280.37 | -1.29% | -2.2% | 14.1x | 0.38 | $254.5B |
| AMGNAMGEN | $349.90 | -0.42% | -6.3% | 15.0x | 0.42 | $188.6B |
| ABTABBOTT | $107.19 | -1.12% | -4.5% | 17.2x | 0.74 | $186.3B |
| GILDGILEAD | $141.06 | -0.17% | -8.6% | 14.7x | 0.37 | $175.2B |
| TMOTHERMO | $470.21 | +1.18% | -6.2% | 17.5x | 0.97 | $174.7B |
Fundamentals
Market Cap$31.6B
P/E (TTM)24.7
Forward P/E17.0
Beta1.31
Div Yield91.00%
Prev Close$111.40
RSI (14-Day)
27Oversold
0305070100
52-Week Range
$96.43$111.72$160.27
From High-30.3%
From Low+15.9%
Moving Averages
50d SMA
$128.19-12.8%
200d SMA
$129.67-13.8%
Price below 200d MA — bearish structure.
Returns
1W
+0.1%
1M
-12.0%
3M
-19.6%
6M
-11.5%
1Y
-8.5%
YTD
-18.9%
Volume
Today70K
20d Avg2.7M
Ratio0.03x